Abstract: Liposomes of a size of less than 200 nanometers target ischemic myocardial tissue and preferentially deliver active agents to infarcted areas.
Abstract: A process for the production of a non-aggregating, filterable dispersion of liposomal encapsulated hemoglobin includes the addition of a plasma protein such as human serum albumin to a liposome dispersion and the application of liposome-forming energy to the dispersion sufficient to form unilamellar vesicles having a diameter smaller than 0.2 .mu.m.
Abstract: Liposomes of a size of less than 200 nanometers target ischemic myocardial tissue and preferentially deliver active agents to infarcted areas in the absence of antibodies bound to the liposomes to effect the delivery.
Abstract: Delivery vehicle formulations comprising active agents encapsulated within microparticles which include a succinimidyl moiety extending externally from a lipid molecule therein are capable of the cytoplasmic or nuclear cell delivery of intact encapsulated active agents.
Abstract: Delivery vehicle formulations comprise active agents encapsulated within liposomal vesicles to which are attached protein hormones (ligands) such as interleukin-2. The ligands are capable of showing affinity for specific cell receptors resulting in delivery of the encapsulated active agent to target cells, enabling delivery of active agents to particular cell populations in the treatment of conditions such as immune system disorders.
Type:
Grant
Filed:
March 10, 1992
Date of Patent:
November 2, 1993
Assignee:
Vestar, Inc.
Inventors:
Paula J. Konigsberg, Leroy L. Richer, Paul G. Schmidt, Joseph A. Uliana
Abstract: A process for the encapsulation of oligonucleotides in liposomes includes the suspending of liposomes containing a divalent cation in a solution containing an oligonucleotide and having an osmolarity of a less than that of the internal aqueous phase.
Abstract: A systemic plant interface replaces the roots of a growing plant by providing a perforate surface which mates to growing xylem tissue of a vascular plant and provides fluid communication and support necessary to sustain the aerial portions of a viable plant.
Abstract: A plant stem is provided with liquid only after the liquid has passed through a membrane having a porosity which is insufficient to permit the passage of microorganisms with the liquid to the stem.
Abstract: A plant stem is sealed aseptically by an initially imperforate, stem-penetrable elastomer which is sufficiently flowable and has sufficient self-affinity to form a seal against the stem which is sufficient to resist the flow of liquid around the stem at a pressure of about 0.9 to about 1.2 psi, and an elastomer is provided containing dispersed, suspended particles of a water-insoluble, hydroscopic polymer.
Abstract: A thin-film evaporator for preparing liposomes in commercial quantities provides a film-forming zone of uniform thickness which enables the uniform evaporation of an organic solvent to form a film of uniform thickness, followed by in situ hydration of the film in an aqueous phase by agitation with a rotor.
Abstract: A single-vessel method is provided for preparing liposomes in commercial quantities by forming a homogeneous and uniform lipid film in a thin-film evaporator by evaporation of the organic solvent, followed by in situ hydration of the film in an aqueous phase by agitation with the rotor.